rs201278923

This variant is located in the HLA-DRB1 gene.

ClinVar annotation

Likely Benign
2 submitters

HLA-DRB1-related disorder; Familial cancer of breast; Uterine corpus endometrial carcinoma; Hepatocellular carcinoma; Nonpapillary renal cell carcinoma; Chronic lymphocytic leukemia/small lymphocytic lymphoma; Colon adenocarcinoma; Colorectal cancer; Acute myeloid leukemia; Malignant tumor of esophagus; Lung cancer

View on ClinVar →

Research that mentions this SNP (5)

Genetic factors for susceptibility to and manifestations of neuromyelitis optica
AssociationN=228Takuya Matsushita et al.(2020)· Annals of Clinical and Translational Neurology

This post-mortem autopsy study of 228 MS brain donors identified four distinct neuropathology-based subgroups using clustering analysis on white matter lesion patterns and microglial characteristics. Genetic validation using 288 MS-associated SNPs found that rs3135388A (HLA-DRB1*15:01 tagging SNP) was significantly associated with two subgroups (p < 0.001), and polygenic risk scores correlated with neuropathological dimensions, suggesting genetic architecture partially underlies MS pathological heterogeneity.

Traits studied:Benign MSMultiple sclerosisPrimary progressive MSRelapsing-remitting MSSecondary progressive MS
Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico
AssociationN=204González-Enríquez GV et al.(2018)· Immunogenetics

This case-control study examined SNP rs3129934, a tag for the HLA-DR2 haplotype (HLA-DRB1*15:01/HLA-DQB1*06:02) that confers risk for multiple sclerosis. All 73 Wixárika (Huichol) indigenous subjects from Mexico were homozygous CC (absence of risk T allele), compared to 25.8% T allele frequency in 60 Mestizo MS patients and 12.7% in 71 healthy Mestizo controls (p<0.0001). The complete absence of the MS risk allele in this unmixed Amerindian population is consistent with the absence of reported MS cases in the Wixárika ethnic group.

Traits studied:Multiple sclerosis
Novel Risk Loci for Rheumatoid Arthritis in Han Chinese and Congruence With Risk Variants in Europeans
ReviewLei Jiang et al.(2014)· Arthritis &amp; Rheumatology

This review examines the relationship between host genetic factors and the microbiome in rheumatoid arthritis (RA). The authors synthesize evidence that 349 SNPs identified through GWAS meta-analyses of >100,000 participants contribute to RA susceptibility, with 100 SNPs replicated. Key genetic loci include HLA-DRB1 (shared epitope), PTPN22, PADI4, STAT4, TNFAIP3, and CARD9. The review discusses how RA-associated genetic variants may influence disease pathogenesis through altered microbiome composition and immune responses to commensal taxa, particularly Prevotella copri and Porphyromonas gingivalis in the gut and oral microbiota.

Traits studied:Rheumatoid arthritisSeronegative RASeropositive RA
Association of anti–citrullinated vimentin and anti–citrullinated α‐enolase antibodies with subsets of rheumatoid arthritis
AssociationN=759Ariana Montes et al.(2012)· Arthritis &amp; Rheumatism

Nested case-control study within the Nurses' Health Study cohorts (192 RA cases, 567 controls) found anti-citrullinated peptide autoantibodies (ACPAs) strongly associated with rheumatoid arthritis risk (RR 4.9), with strongest association within 5 years of onset (RR 17.6). HLA-DRB1 shared epitope alleles and ACPA positivity together conferred 10-fold increased risk overall and 33-fold within 5 years. HLA-SE-positive cases showed reactivity to more ACPA peptide types.

Traits studied:Pre-clinical rheumatoid arthritisRheumatoid arthritis
The immunogenetics of multiple sclerosis
ReviewArne Svejgaard et al.(2008)· Immunogenetics

MedlinePlus Genetics educational summary describing the HLA-DQB1 gene function and its associations with multiple autoimmune diseases including celiac disease (DQ2/DQ8 haplotypes), narcolepsy (HLA-DQB1*06:02), type 1 diabetes (DR3/DR4 haplotypes), and multiple sclerosis. The DQ2 and DQ8 haplotypes are present in 30% of the general population but only 3% with these variants develop celiac disease, indicating additional genetic and environmental factors required for disease manifestation.

Traits studied:Alopecia areataAutoimmune Addison diseaseCeliac diseaseJuvenile idiopathic arthritisMultiple sclerosisNarcolepsyPemphigusRosaceaType 1 diabetes

About HLA-DRB1

HLA-DRB1 belongs to the HLA class II beta chain paralogs. The class II molecule is a heterodimer consisting of an alpha (DRA) and a beta chain (DRB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells. The beta chain is approximately 26-28 kDa. It is encoded by 6 exons. Exon one encodes the leader peptide; exons 2 and 3 encode the two extracellular domains; exon 4 encodes the transmembrane domain; and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Hundreds of DRB1 alleles have been described and some alleles have increased frequencies associated with certain diseases or conditions. For example, DRB1*1302 has been related to acute and chronic hepatitis B virus persistence. There are multiple pseudogenes of this gene. [provided by RefSeq, Jul 2020]

View all HLA-DRB1 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…